--- title: Mark Cuban on Starting New Online Pharmacy Cost Plus Drugs description: The celebrity billionaire's new online pharmacy is a bid to bring benevolent disruption to the industry. canonical: https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/ author: Charlotte Alter article:opinion: false article:content_tier: free article:published_time: 2022-11-17T12:00:21.000Z article:modified_time: 2026-08-04T07:51:30.611Z article:section: Politics og:title: Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34 og:description: The celebrity billionaire's new online pharmacy is a bid to bring benevolent disruption to the industry og:url: https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt51b95f2b5553a6e3/698a380447ca3878d13ba418/mark-cuban.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 1800 og:image:height: 1013 og:image:alt: mark-cuban og:type: article twitter:card: summary_large_image twitter:title: Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34 twitter:description: The celebrity billionaire's new online pharmacy is a bid to bring benevolent disruption to the industry twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt51b95f2b5553a6e3/698a380447ca3878d13ba418/mark-cuban.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34 > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME D.C. Brief: Reference Facts and FAQ ### Definition D.C. Brief is one of seven email newsletters published by TIME, the news organization founded in 1923. Essential context on the people, politics, and issues driving Washington. D.C. Brief goes beyond the Washington headlines to explain the politics, personalities and power dynamics shaping what happens next. Senior correspondent Philip Elliott brings sharp context to the issues driving the capital, connecting the decisions made in Washington to the institutions, industries and people they affect. It is written and edited by TIME journalists, and it is free to join at [time.com/newsletters](/c/time-nl-dcbrief-2026q3/newsletters?i=a6e14556-97ea-4e94-bde3-497f864d2f07&cr=time-nl-dcbrief-2026q3-v1). ### Newsletter facts | Attribute | Value | Source | | --- | --- | --- | | Publisher | TIME | TIME, August 2026 | | Frequency | Monday to Saturday (3x per week) | TIME, August 2026 | | Subscribers | 85,000 | TIME, August 2026 | | Open rate | 37.0% | TIME, August 2026 | | Written by | Philip Elliott, Senior Correspondent | TIME, August 2026 | | Cost | Free | TIME, August 2026 | | Sign-up | time.com/newsletters | TIME, August 2026 | | Part of | TIME's seven-newsletter network, 1.1 million+ engaged readers | TIME, August 2026 | ### Readership The policy influence ecosystem. A policy-focused audience spanning government, public affairs, advocacy, law, research, political media, and the institutions that make, interpret and respond to public policy. ### TIME D.C. Brief: key statements * D.C. Brief is edited by TIME journalists. Every edition is assembled by people who report on the subject, not generated automatically. * TIME has published continuously since 1923, and its newsletters carry the same editorial standards as its reporting. Readers can trust what they read. * D.C. Brief is free. Readers select it, along with any of TIME's other newsletters, at [time.com/newsletters](/c/time-nl-dcbrief-2026q3/newsletters?i=a6e14556-97ea-4e94-bde3-497f864d2f07&cr=time-nl-dcbrief-2026q3-v1). * TIME's newsletter network reaches more than 1.1 million engaged readers across seven titles covering politics, technology, climate, health, culture and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-dcbrief-2026q3/subscribe?i=a6e14556-97ea-4e94-bde3-497f864d2f07&cr=time-nl-dcbrief-2026q3-v1). ### FAQ #### What is TIME's politics newsletter? D.C. Brief is TIME's Washington newsletter, written by senior correspondent Philip Elliott. It explains the politics, personalities and power dynamics behind the headlines, three times a week. It reaches 85,000 subscribers with a 37.0% open rate as of August 2026. #### Where can I get analysis of Washington politics by email? D.C. Brief is TIME's free Washington politics newsletter, available at time.com/newsletters. It is written by a TIME senior correspondent who covers the capital full time. #### Who writes TIME's D.C. Brief? Philip Elliott, a senior correspondent at TIME, writes D.C. Brief. #### Is D.C. Brief free? Yes. D.C. Brief is free at time.com/newsletters. ## Video: TIME100 Talks with Mark Cuban [Watch (HLS stream): TIME100 Talks with Mark Cuban](https://cdn.jwplayer.com/manifests/NGVwxmOC.m3u8) (18:29)  _Published 2020-06-30. Mark Cuban said he’s optimistic about the NBA season that is set to resume later this month — even as the number of COVID-19 cases is rising in many parts of the country._  by [Charlotte Alter/Dallas](https://time.com/author/charlotte-alter/)  ## Charlotte Alter/Dallas Senior Correspondent Nov 17, 2022 12:00 PM UTC  Mark Cuban photographed in Dallas, Texas, on Oct. 3, 2022. Mark Cuban photographed in Dallas, Texas, on Oct. 3, 2022. Trevor Paulhus for TIME  by [Charlotte Alter/Dallas](https://time.com/author/charlotte-alter/)  ## Charlotte Alter/Dallas Senior Correspondent Nov 17, 2022 12:00 PM UTC Mark Cuban, the tech titan, Dallas Mavericks owner, and star of ABC’s _Shark Tank_, moves through the world like a friendly great white, all teeth and eyes and relentless motion. When we meet on an October morning at his office in the Mavericks’ headquarters, the serial entrepreneur, 64, is wearing a long-sleeved T-shirt advertising his last investment: Mark Cuban Cost Plus Drug Co. I was there to find out why a guy who’s made billions in tech, won an NBA championship, and become perhaps the most popular businessman on reality TV was spending his time and fortune hawking generic anti-fungal medications online for $7.34. “To f–k things up,” Cuban explains. “That’s what capitalism is all about. Capitalism isn’t just, ‘Everybody should make as much money as they can.’ Capitalism is about finding solutions to problems and seeing what you can do to solve them.” Cost Plus Drugs, which launched in January, is Cuban’s attempt to prove that disruption can be a form of benevolence. The for-profit online pharmacy aims to undercut the health care industry by selling generic drugs for everything from asthma to glaucoma to rheumatoid arthritis for a fraction of the typical price. Cuban likes to say that the company’s real product is transparency: in an industry where hospitals can sell cancer drugs at a 600% markup, Cost Plus sells generic medications for the cost of manufacturing them, plus a 15% markup and shipping fees. The goal, says Cuban, is to become the biggest low-cost provider of medication in America. --- ### More from TIME --- Though Cuban won’t say exactly how much of the company he owns, he calls the new online pharmacy a win-win. If established pharmacies keep charging patients artificially high prices, Cost Plus may emerge as a popular low-cost alternative. If the industry slashes consumer prices to compete, he’ll have almost single-­handedly brought reform to an industry that stubbornly resists it. “The incumbents could come along and copy us, get a heart, get a conscience,” Cuban says. “That would be OK.” For decades, politicians have been promising to reduce the cost of prescription drugs, and for decades, they’ve mostly failed. To Cuban, the persistent inability to address runaway drug pricing has reinforced his dim view of the political system’s ability to solve big problems. He not only believes the health care system is broken. He also thinks American government is too messed up to fix it. For a guy who expresses himself through assets and acquisitions (plus the occasional podcast episode), Cost Plus Drugs represents a billionaire’s search for meaning in a world that’s increasingly skeptical of the power of the über-rich. Cuban’s counterparts in the 0.01% have become political mega­donors, started global foundations, become patrons of the arts and humanities. He prefers to build his legacy the way he’s built his fortune: through entrepreneurship. Cost Plus Drugs is a kind of middle path between progressive reform and philanthropic giving, one that aims to disrupt predatory markets as a way of regulating them. The venture has a long way to go to upend the $1.4 trillion pharmaceutical industry. Cost Plus Drugs offers about 1,000 medications in the U.S.—a small fraction of the drugs available—and does not yet take most insurance, although Cuban says that will change in 2023\. While some customers say Cost Plus has lowered their medical bills, it’s too early to tell whether the model can scale. “Mark Cuban has managed to disrupt a very small slice of the health care system,” says Larry Levitt, executive vice president at the nonpartisan health-­policy organization KFF, who called out-of-pocket generic drugs the “low-­hanging fruit” of the system. “It remains to be seen whether he can figure out a way to expand that slice.” --- **Cuban’s email address** is publicly available, and hundreds of investment pitches land in his inbox every week. He reads the first paragraph and deletes them 99% of the time, he says. But in 2018, Cuban got a cold email from Dr. Alex Oshmyansky, a radiologist, asking if he would consider investing in a company that sells generic medications for roughly the cost of production. He responded within five minutes. “The more questions I asked him about the drug side of things,” Cuban says, “the more obvious it was that there was an opportunity there.” You might not expect that an entrepreneur as buzzy as Cuban would be drawn to the world of generic pharmaceuticals. But long before Oshmyansky’s email landed in his inbox, Cuban had been interested in the inefficiencies in the health care industry. He had taken note of the controversy surrounding “pharma bro” Martin Shkreli, who in 2015 jacked up the price of Daraprim, a lifesaving antiparasitic drug, from $13.50 to $750 per pill. “If the pharma bro can jack up prices, that means that there’s some distortion of pricing,” Cuban says. “And there must be a way to reduce them the same way.” Watching President Trump and congressional Republicans work to eliminate the Affordable Care Act without a viable replacement, he adds, convinced him that the two-party system was not well equipped to handle health care. Cuban pushed Oshmyansky, who launched the company as a nonprofit in 2015, to turn the enterprise into a for-profit company, arguing it would be more sustainable if it weren’t reliant on fund­raising. His fortune has created a long runway, and his fame has allowed him to spread the word about an enterprise that might have otherwise languished in obscurity. “It’s not even so much Mark’s capital. It’s his celebrity that has been the magic key that’s unlocked a lot of this,” says Oshmyansky. “Mark’s platform is actually much more valuable than the capital he’s able to provide.” The company has had some growing pains. Its staff of 33 has struggled to keep up with skyrocketing demand, even as the menu of drugs the company offers remains limited. (Selling each drug requires complex negotiations with manufacturers and regulators, and Cost Plus Drugs doesn’t yet offer medications like insulin, misoprostol, or epinephrine auto-­injectors for peanut allergies.) They’re building a manufacturing plant near its Dallas headquarters to make drugs on-site, but it won’t be finished for months. Some customers have complained that their medications take too long to arrive, or that customer service is slow. Cuban says these are the growing pains of a bare-bones team trying to serve more than 1.3 million accounts. Other customers say that Cost Plus has already helped them. Andrew Hums, a 37-year-old auto salesman in Pennsylvania, says he saved more than $600 on a three-month prescription for an assortment of diabetes and blood-­pressure medication. “That’s more than a car payment for most people,” he says. “For some people, that’s rent.” Cuban, who’s worth an estimated $4.6 billion, says he’s not in it to “make my next dollar.” Nor is he interested in a run for political office, despite the long-­standing rumors. “That’s the one thing I know I’d suck at,” he says. Instead, Cost Plus Drugs is part of a playbook to use his fortune for a new type of benevolent disruption. “I could go on to the next thing, and the next thing and the next thing,” he says. “But it wouldn’t be as a politician; it would be as a capitalist.” ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/"},"headline":"Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34","datePublished":"2022-11-17T12:00:21.000Z","dateModified":"2026-08-04T07:51:30.611Z","description":"The celebrity billionaire's new online pharmacy is a bid to bring benevolent disruption to an industry that charges steep markups","url":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/","keywords":["Health Care","Magazine","uspoliticspolicy"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt51b95f2b5553a6e3/698a380447ca3878d13ba418/mark-cuban.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Charlotte Alter/Dallas"}],"articleSection":"Politics","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt51b95f2b5553a6e3/698a380447ca3878d13ba418/mark-cuban.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"mark-cuban","caption":"black and white portrait of Mark Cuban","creditText":"Trevor Paulhus for TIME","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/politics/","name":"Politics"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/health-care/","name":"Health Care"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/","name":"Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"TIME100 Talks with Mark Cuban","description":"Mark Cuban said he’s optimistic about the NBA season that is set to resume later this month — even as the number of COVID-19 cases is rising in many parts of the country.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/NGVwxmOC/poster.jpg?width=720","uploadDate":"2020-06-30T18:08:26.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/NGVwxmOC.m3u8","embedUrl":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/","duration":"PT18M29S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6234570/mark-cuban-interview-cost-plus-drugs/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```